Crocs (CROX) Tops Q3 EPS by 50c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St futures rise on Mideast deal optimism; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Crocs (CROX) PT Lowered to $138 at Stifel, 'Brand and Improving Balance Sheet Support Risk/Reward'
October 30, 2024 7:00 AM EDTStifel analyst Jim Duffy lowered the price target on Crocs (NASDAQ: CROX) to $138.00 (from $158.00) while maintaining a Buy rating.
The analyst comments "3Q24 revenue (+$16mn) and adj. EPS upside (+$0.52) benefited from a pull-forward of wholesale orders, and 4Q24 revenue and adj.... More
BNP Paribas Exane on Crocs (CROX): 'We believe results and guidance for the Crocs brand were generally in-line with expectation'
October 30, 2024 6:59 AM EDTBNP Paribas Exane analyst Aubrey Tianello reiterated a Neutral rating and $128.00 price target on Crocs (NASDAQ: CROX).
The analyst comments "What happened? CROX reported a 3Q24 beat with revs of $1.06bn (+2% y/y) vs. cons of $1.05bn and adjusted EPS of $3.60 vs. cons of $3.10. We believe results and guidance for the Crocs brand were generally in-line with expectations. However, HEYDUDE guidance was materially cut again, putting pressure on shares pre-mkt. We provide thoughts ahead of the 8:30am ET conf. call. BNPP Exane View: 1Q results beat on Crocs strength, but HEYDUDE... More
Crocs (CROX) PT Lowered to $125 at Barclays
October 29, 2024 2:36 PM EDTBarclays analyst Adrienne Yih lowered the price target on Crocs (NASDAQ: CROX) to $125.00 (from $164.00) while maintaining a Overweight rating.
The analyst comments "3Q24 results beat expectations on sales, OM, and EPS, mostly driven by SG&A leverage. Despite the... More
Crocs (CROX) PT Lowered to $140 at Williams Trading
October 29, 2024 2:21 PM EDTWilliams Trading analyst Sam Poser lowered the price target on Crocs (NASDAQ: CROX) to $140.00 (from $163.00) while maintaining a Buy rating.
The analyst comments "Lowering PT from $163 to $140, raising FY24 estimates, lowering FY25 estimates, and introducing FY26 estimates. The better than expected 3Q24 results were driven by a 7.5% increase in Crocs revenue, which beat consensus by 2.5%,... More
